SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2.

📊

Key Findings & Data:The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak.

💡

Conclusion & Impact:This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

🔬Design:Research Article

📍Scope:2019 Verileri

⚙️Variables:Domain Parameters

Abstract

The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

🔖

Cite This Article

OVALI, E., ELMAS, M. A., ARBAK, S., TAŞTAN, C., KANÇAĞI, D. D., YURTSEVER, B., ABANUZ, S., SEYİS, U., BİRDOĞAN, S., KOCAGÖZ, A. S., YALÇIN, K., KARAKUŞ, G. S., YILDIRIM, M., KUZAY, R., ELİBOL, Ö., SEZERMAN, O. U., DEMİR, S. (2022). SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients. Turkish Journal of Biology, Cilt: 44 - Sayı: 3, 192–202. https://ajindex.com/articles/654388

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (8)

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (2020). The proximal origin of SARS-CoV-2. Nature Medicine 26: 450- 52. doi: 10.1038/s41591-020-0820-9
Baer A, Kylene KH (2014). Viral concentration determination through plaque assays: using traditional and novel overlay systems. Journal of Visualized Experiments 93: 1-10. doi: 10.3791/52065
Cui J, Fang L, Zheng LS (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17: 181-192. doi: 10.1038/s41579-018-0118-9
Guallart N (2015). An overview of virus qunatification techniques. Axiomathes 25: 61-77. doi: 10.1007/s10516-014-9260-9
Harcourt J, Tamin A, Lu X, Kamili S, Kumar S (2020). Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. bioRxiv doi: https://doi.org/10.1101/2020.03.02.972935
He L, Ding Y, Zhang Q, Che X, He Y et al. (2006). Expression of elevated levels of pro-inflammatory cytokines in SARS-CoVinfected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS288–97. The Journal of Pathology 210 (3): 288-297. doi: 10.1002/path Holshue ML, DeBoltC, Lindquist S, Lofy KH, Wiesman J et al. (2020). First case of 2019 novel coronavirus in the United States. The New England Journal of Medicine 382 (10): 929- 936. doi: 10.1056/NEJMoa2001191 Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Kent Tseng CT et al. (2015). Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. Journal of Virology 89 (6): 2995-3007. doi: 10.1128/jvi.02980-14
Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R (2020). The continuing 2019-NCoV epidemic threat of novel cCoronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases 91: 264-266. doi: 10.1016/j. ijid.2020.01.009 Li CK, Wu H, Yan H, Ma S, Wang L et al. (2008). T cell responses to whole SARS coronavirus in humans.The Journal of Immunology 181 (8): 5490-5500. doi: 10.4049/jimmunol.181.8.5490 Li Q, Guan X, Wu P, Wang X, Zhou L et al. (2020).
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine 382 (13): 1199-1207. doi: 10.1056/NEJMoa2001316 Libraty DH, O’Neil KM, Baker LM, Acosta LP, Olveda RM (2007). Human CD4+ memory T-lymphocyte responses to SARS coronavirus infection.Virology 368 (2): 317-321. doi: 10.1016/j. vi